Uzun, N. Et Al. 2023. Cardiovascular Disease Risk in Children and Adolescents with Attention Deficit/Hyperactivity Disorder. CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE , vol.21, no.1 , 77-87.

Uzun, N., Akıncı, M. A., & Alp, H., (2023). Cardiovascular Disease Risk in Children and Adolescents with Attention Deficit/Hyperactivity Disorder. CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE , vol.21, no.1, 77-87.

Uzun, Necati, Mehmet Akif AKINCI, And Hayrullah Alp. "Cardiovascular Disease Risk in Children and Adolescents with Attention Deficit/Hyperactivity Disorder," CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE , vol.21, no.1, 77-87, 2023

Uzun, Necati Et Al. "Cardiovascular Disease Risk in Children and Adolescents with Attention Deficit/Hyperactivity Disorder." CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE , vol.21, no.1, pp.77-87, 2023

Uzun, N. Akıncı, M. A. And Alp, H. (2023) . "Cardiovascular Disease Risk in Children and Adolescents with Attention Deficit/Hyperactivity Disorder." CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE , vol.21, no.1, pp.77-87.

@article{article, author={Necati Uzun Et Al. }, title={Cardiovascular Disease Risk in Children and Adolescents with Attention Deficit/Hyperactivity Disorder}, journal={CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE}, year=2023, pages={77-87} }